Search Results 51-60 of 21320 for anti-TNF drugs

1. Adalimumab-Fkjp (Subcutaneous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

2. Etanercept-Szzs (Subcutaneous Route) Before Using - Mayo Clinic

   Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...

3. Etanercept-Szzs (Subcutaneous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

4. A Study to Assess Whether Etrolizumab is a Safe and Effective Treatment for Participants with Moderately to Severely Active Crohn's Disease (CD) - Mayo Clinic

   Anti-TNF Therapy. Inadequate primary non-response: Did not respond (as ... Chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs). Prophylactic ...

5. Rheumatoid Arthritis Clinical Trials - Mayo Clinic Research

   ... treatment with modifying antirheumatic drugs (DMARDs) or anti-TNF alpha agents. Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis ...

6. Weekend Wellness: Ankylosing spondylitis symptom changes hard to predict - Mayo Clinic News Network

   When these symptoms are persistent, treatment usually involves medications known as TNF blockers. ... Examples of these medications include adalimumab, etanercept ...

7. Adalimumab-Fkjp (Subcutaneous Route) Side Effects - Mayo Clinic

   Side Effects. Drug information provided by: Merative, Micromedex®. Along with its needed effects, a medicine may cause some unwanted effects. Although not ...

8. A Study to Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy - Mayo Clinic

   * Must have failed anti-TNF treatment for HS. * To be eligible for the Sub-study, participants must be naïve to biologic therapy for treatment of HS.

9. Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year - Mayo Clinic

   The purpose of this study is to compare the efficacy of treatment with ustekinumab or adalimumab in biologic naive participants with moderately-to-severely ...

10. Mayo Clinic Q&A podcast Dr. Faubion IBD

    drugs begin to affect the immune system body wide, okay. ... All of these affect TNF, we call them anti TNF. ... Does it traffic to the colon or not, the so-called ...